International Agency for Research on Cancer (IARC-WHO), Lyon, France.
BMJ. 2010 Jan 21;340:b5500. doi: 10.1136/bmj.b5500.
To examine the association between pre-diagnostic circulating vitamin D concentration, dietary intake of vitamin D and calcium, and the risk of colorectal cancer in European populations.
Nested case-control study. Setting The study was conducted within the EPIC study, a cohort of more than 520 000 participants from 10 western European countries.
1248 cases of incident colorectal cancer, which developed after enrolment into the cohort, were matched to 1248 controls
Circulating vitamin D concentration (25-hydroxy-vitamin-D, 25-(OH)D) was measured by enzyme immunoassay. Dietary and lifestyle data were obtained from questionnaires. Incidence rate ratios and 95% confidence intervals for the risk of colorectal cancer by 25-(OH)D concentration and levels of dietary calcium and vitamin D intake were estimated from multivariate conditional logistic regression models, with adjustment for potential dietary and other confounders.
25-(OH)D concentration showed a strong inverse linear dose-response association with risk of colorectal cancer (P for trend <0.001). Compared with a pre-defined mid-level concentration of 25-(OH)D (50.0-75.0 nmol/l), lower levels were associated with higher colorectal cancer risk (<25.0 nmol/l: incidence rate ratio 1.32 (95% confidence interval 0.87 to 2.01); 25.0-49.9 nmol/l: 1.28 (1.05 to 1.56), and higher concentrations associated with lower risk (75.0-99.9 nmol/l: 0.88 (0.68 to 1.13); >or=100.0 nmol/l: 0.77 (0.56 to 1.06)). In analyses by quintile of 25-(OH)D concentration, patients in the highest quintile had a 40% lower risk of colorectal cancer than did those in the lowest quintile (P<0.001). Subgroup analyses showed a strong association for colon but not rectal cancer (P for heterogeneity=0.048). Greater dietary intake of calcium was associated with a lower colorectal cancer risk. Dietary vitamin D was not associated with disease risk. Findings did not vary by sex and were not altered by corrections for season or month of blood donation.
The results of this large observational study indicate a strong inverse association between levels of pre-diagnostic 25-(OH)D concentration and risk of colorectal cancer in western European populations. Further randomised trials are needed to assess whether increases in circulating 25-(OH)D concentration can effectively decrease the risk of colorectal cancer.
探讨欧洲人群中诊断前循环维生素 D 浓度、维生素 D 和钙的饮食摄入量与结直肠癌风险之间的关系。
巢式病例对照研究。地点:该研究在 EPIC 研究中进行,该队列由来自 10 个西欧国家的 520000 多名参与者组成。
1248 例结直肠癌新发病例,在队列入组后发生,与 1248 例对照相匹配。
通过酶联免疫吸附试验测定循环维生素 D 浓度(25-羟维生素 D,25-(OH)D)。饮食和生活方式数据通过问卷调查获得。通过多变量条件逻辑回归模型,估计 25-(OH)D 浓度和饮食钙及维生素 D 摄入量水平与结直肠癌风险的比值比(95%置信区间),并对潜在的饮食和其他混杂因素进行调整。
25-(OH)D 浓度与结直肠癌风险呈强负线性剂量反应关系(趋势 P<0.001)。与预定义的 25-(OH)D 中值浓度(50.0-75.0 nmol/l)相比,较低的浓度与较高的结直肠癌风险相关(<25.0 nmol/l:发病率比 1.32(95%置信区间 0.87 至 2.01);25.0-49.9 nmol/l:1.28(1.05 至 1.56),较高的浓度与较低的风险相关(75.0-99.9 nmol/l:0.88(0.68 至 1.13);≥100.0 nmol/l:0.77(0.56 至 1.06))。按 25-(OH)D 浓度五分位进行分析,浓度最高的五分位数患者的结直肠癌风险比浓度最低的五分位数患者低 40%(P<0.001)。亚组分析显示结肠癌相关性强,直肠癌相关性弱(异质性 P=0.048)。较高的膳食钙摄入量与结直肠癌风险较低相关。膳食维生素 D 与疾病风险无关。这些发现不因性别而变化,且不受血液采集季节或月份的校正影响。
这项大型观察性研究的结果表明,在欧洲人群中,诊断前 25-(OH)D 浓度与结直肠癌风险之间存在很强的负相关关系。需要进一步的随机试验来评估循环 25-(OH)D 浓度的增加是否能有效降低结直肠癌的风险。